Over the years, the scientific importance of nanoparticles for biomedical applications has
increased. The high stability and biocompatibility, together with the low toxicity of the …

Recent advances in the development of magnetic nanoparticles (MNPs) have shown
promise in the development of new personalized therapeutic approaches for clinical …

Inflammation is a pivotal driver of atherosclerotic plaque progression and rupture and is a
target for identifying vulnerable plaques. However, challenges arise with the current in vivo …

Superparamagnetic iron oxide MR imaging contrast agents have been the subjects of
extensive research over the past decade. The iron oxide particle size of these contrast …

Magnetism in medicine has had a long and interesting history. In the 10th century AD,
Egyptian physician and philosopher Avicenna prescribed a grain of magnetite dissolved in …

Rapid point-of-care (POC) diagnostics that enable specific cellular and molecular detection
are currently being developed while some have already become clinical reality. These …

Synthetic magnetic nanoparticles (MNPs) are emerging as versatile probes in biomedical
applications, especially in the area of magnetic resonance imaging (MRI). Their size, which …

A comprehensive classification of contrast agents currently used or under development for
magnetic resonance imaging (MRI) is presented. Agents based on small chelates …

Ferucarbotran (Resovist) is the second clinically approved superparamagnetic iron oxide
developed for contrast-enhanced MRI of the liver. The purpose of this review is to provide an …

Simple Summary Magnetic nanoparticles (MNPs) are highly efficient contrast agents for
magnetic resonance imaging for various types of tumors. This review focuses on the various …